4//SEC Filing
Chagin Karen Deborah 4
Accession 0001842952-25-000056
CIK 0001842952other
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 5:22 PM ET
Size
5.7 KB
Accession
0001842952-25-000056
Insider Transaction Report
Form 4
Chagin Karen Deborah
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2025-06-09+153,000→ 153,000 totalExercise: $0.70Exp: 2035-06-08→ Common Stock (153,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on June 9, 2026, and the balance vests in equal monthly installments over the remaining three years of the four-year period, subject to continued service with the Issuer.
Documents
Issuer
Context Therapeutics Inc.
CIK 0001842952
Entity typeother
Related Parties
1- filerCIK 0002070710
Filing Metadata
- Form type
- 4
- Filed
- Jun 8, 8:00 PM ET
- Accepted
- Jun 9, 5:22 PM ET
- Size
- 5.7 KB